Sunny Pharmtech Inc. (TPEX:6676)
Taiwan · Delayed Price · Currency is TWD 12.35
+0.20 (1.65%)
Aug 26, 2026, 1:49 PM CST
Sunny Pharmtech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 233.36 | 253.01 | 418.01 | 428.83 | 359.59 | 241 |
Revenue Growth | -7.77% | -39.47% | -2.52% | 19.26% | 49.21% | -42.61% |
Gross Profit Gross Profit Growth | 36.96 | 73.14 | 226.4 | 285.53 | 206.71 | 115.75 |
Operating Income Operating Income Growth | -350.09 | -317.53 | -162.99 | -72.1 | -187.62 | -176 |
Net Income Net Income Growth | -325.13 | -302.05 | -156 | -63.32 | -170.24 | -174.79 |
Earnings Per Share EPS Growth | -2.14 | -2.03 | -1.05 | -0.44 | -1.23 | -1.31 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 103.83 | 103.83 | 75.14 | 72.63 | 359.59 | 241 |
United States United States Growth | 146.57 | 146.57 | 315.43 | 347.15 | - | - |
Others Others Growth | 2.61 | 2.61 | 27.45 | 9.05 | - | - |
Total Total Growth | 253.01 | 253.01 | 418.01 | 428.83 | 359.59 | 241 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 94.41 | 47.77 | 138.02 | 270.56 | 271.14 | 241.5 |
Total Debt Total Debt Growth | 311.67 | 484.37 | 386.29 | 391.43 | 562.69 | 366.3 |
Net Cash (Debt) Net Cash Growth | -217.26 | -436.61 | -248.27 | -120.87 | -291.55 | -124.8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.43 | -2.93 | -1.67 | -0.85 | -2.10 | -0.93 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -153.58 | -158.99 | -37.1 | 38.1 | 26.88 | -34.35 |
Capital Expenditures CapEx Growth | -33.13 | -29.33 | -45.71 | -143.99 | -179.18 | -158.95 |
Free Cash Flow Free Cash Flow Growth | -186.71 | -188.32 | -82.81 | -105.88 | -152.3 | -193.31 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 15.84% | 28.91% | 54.16% | 66.58% | 57.48% | 48.03% |
Operating Margin | -150.02% | -125.50% | -38.99% | -16.81% | -52.18% | -73.03% |
Pretax Margin | -139.33% | -119.38% | -37.32% | -14.77% | -47.34% | -72.53% |
Profit Margin | -139.33% | -119.38% | -37.32% | -14.77% | -47.34% | -72.53% |
FCF Margin | -80.01% | -74.43% | -19.81% | -24.69% | -42.35% | -80.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 7.75 | 8.21 | 7.88 | 11.93 | 7.61 | - |